SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-124625
Filing Date
2021-10-08
Accepted
2021-10-08 16:19:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2129349-1_424b5.htm 424B5 482696
2 GRAPHIC lg_arbutusbiopharma-4c.jpg GRAPHIC 96260
3 GRAPHIC lg_arbutusbio-4c.jpg GRAPHIC 80298
  Complete submission text file 0001104659-21-124625.txt   723528
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-248467 | Film No.: 211315530
SIC: 2834 Pharmaceutical Preparations